乳腺癌放疗后心血管发病与死亡的系统综述与荟萃分析
结果显示放疗增加心力衰竭风险(HR 1.37),左侧放疗增加冠心病风险(HR 1.11),心脏平均剂量与心脏发病呈线性相关(HR 1.12),1989年后左侧放疗的心脏死亡风险降低。
要点
- 乳腺癌放疗与心力衰竭风险增加相关(HR 1.37)。
- 左侧放疗者后续冠心病风险增高(HR 1.11)。
- 心脏平均剂量与心脏发病线性相关(HR 1.12)。
核心结论
- 乳腺癌放疗与不良心血管事件风险增加相关,且高度依赖心脏照射剂量。
- 随着放疗技术进步,心血管预后有望进一步改善。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、EMBASE和Cochrane Library自建库至2024年12月1日。
- 采用随机效应模型合并效应量,并进行亚组分析和发表偏倚评估。
主要发现
- 与未接受放疗者相比,放疗者发生心力衰竭的风险增加(HR 1.37;95%CI 1.20-1.57)。
- 在接受放疗的患者中,左侧放疗增加后续冠心病风险(HR 1.11;95%CI 1.05-1.16)。
- 心脏平均暴露剂量与心脏发病呈线性相关(HR 1.12;95%CI 1.05-1.19)。
- 按治疗时期分组,1989年后左侧放疗患者的心脏死亡风险降低(HR 1.30 vs 1.02,p<0.01)。
- 未发现显著发表偏倚。
临床怎么用
- 对乳腺癌放疗患者应关注心力衰竭和冠心病风险,尤其左侧放疗者。
- 心脏平均剂量与心脏发病相关,提示放疗计划中应尽量降低心脏照射剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiation exposure of the heart secondary to radiotherapy can lead to potential cardiac injury. However, the hazard ratio (HR) for cardiac morbidity and mortality associated with undergoing breast cancer radiotherapy remains unknown. OBJECTIVES: To pool the HRs for cardiovascular risk in patients with breast cancer treated with or without radiotherapy, compare the cardiac risk among irradiated patients divided by the laterality of radiotherapy and further assess the association between the cardiac radiation dose and cardiac morbidity. METHODS: A literature search was conducted using MEDLINE, EMBASE and the Cochrane Library from inception to 1 December 2024. Studies that reported HRs with 95% CIs for the associations of interest were included. Pooled effect estimates were obtained using random-effects meta-analysis. Subgroup analyses were carried out to investigate the influence of the treatment period on cardiovascular outcomes. Publication bias was evaluated using the Egger and Begger's tests. RESULTS: Thirty-one studies involving 610 690 participants were ultimately included. Compared with patients who did not receive radiotherapy, patients who underwent radiotherapy experienced increased risks for developing heart failure (HR: 1.37; 95% CI 1.20 to 1.57). Among patients treated with radiotherapy, left-sided radiotherapy increased the risk of subsequent coronary artery disease (HR: 1.11; 95% CI 1.05 to 1.16). There was a linear correlation between the mean heart exposure dose and cardiac morbidity development (HR: 1.12; 95% CI 1.05 to 1.19). When patients were grouped by treatment period, the risk of cardiac mortality in patients treated with left-sided radiotherapy decreased after 1989 (HR: 1.30 vs 1.02, p<0.01*). No evidence of significant publication bias was identified. CONCLUSIONS: Radiotherapy for breast cancer was associated with an increased risk of experiencing adverse cardiovascular events, which was highly dependent on the cardiac irradiation dose. With advances in radiation techniques, cardiovascular prognosis is expected to improve further.
引用
- Yang MX, Liu JK, Deng HP, et al. Cardiovascular morbidity and mortality after radiotherapy for breast cancer: a systematic review and meta-analysis. Heart. 2025. PMID: 40348406. doi:10.1136/heartjnl-2024-325179
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。